In addition to its essential roles in redox homeostasis it functions as cofactors for a multitude of enzymes
VK0214, oral TR agonist for X-linked adrenoleukodystrophy (X-ALD) Recent Highlights: In June 2026, Viking announced that its working toward maintenance-dosing data for subcutaneous VK2735 and preparing to start Phase 3 trials of the oral tablet in Q4 2026, with the goal of becoming the first company to offer a dual GLP-1/GIP agonist in both oral and injectable form
(PubMed) Marx W, Teleni L, Opie RS, et al
Sn phm gip lm trng da, ngn nga lo ha v ci thin cc vn v da nh nm, tn nhang, np nhn, Ngoi ra, vin ung cn gip tng cng sc khe v phng nga cc bnh
UK Clinical studies have indicated that Tesamorelin may reduce body fat and visceral adipose tissue and improve insulin sensitivity, suggesting its potential for supporting those with metabolic challenges like diabetes mellitus
D) Forma anormal u otras anormalidades (grado IV)